This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Disease activity score (DAS) in rheumatoid arthritis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The disease activity score (DAS) is a scoring system developed in Europe for assessing the severity of rheumatoid arthritis

  • calculated using a formula that includes counts for tender and swollen joints (53 and 44 joints respectively), an evaluation of general health by the patient (on a scale of 0 to 100), and a measure of circulating inflammatory markers

DAS28 is similar to DAS above but uses only 28 joints for assessment

  • DAS28 score greater than 5.1 is considered to be indicative of high disease activity, between 5.1 and 3.2 of moderate disease activity and less than 3.2 of low disease activity
  • a patient scoring less than 2.6 is defined as being in remission
  • the European League Against Rheumatism (EULAR) response criteria are based on the DAS measure
    • a decrease in DAS28 score of 0.6 or less is considered to show a poor response, while decreases greater than 1.2 points indicate a moderate or good response, dependent on whether an individual's DAS28 score at the end point is above or below 3.2 respectively

Reference:


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.